Delic Holdings Corp.

Delic Holdings Corp.

Delic Labs President and CSO Dr. Markus Roggen to Discuss the Importance of R&D for Business Growth at MJBizCon

Dr. Markus Roggen, President and Chief Science Officer for Delic Labs, will participate in a panel discussion about building scientific trust and using research and development to differentiate a brand and maximize revenuesVANCOUVER, BC, Oct. 27, 2022 - Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new m... Read More...

Ketamine Wellness Centers (KWC) Expands Insurance Coverage with Medicare for Ketamine Therapy Patients

KWC will serve more patients than any other ketamine therapy provider with addition of Medicare, cements status as nation's largest ketamine clinic network in the U.S.  Medicare coverage will be available for patients in eight cities with more to come GILBERT, Ariz., Sept. 29, 2022 - Ketamine Wellness Centers (KWC), the largest ketamine t... Read More...

Delic Corp to Present on Strategy and Expansion of Nation’s Largest Ketamine Clinic Network at H.C. Wainwright Annual Global Investment Conference

Matt Stang, executive chairman of Delic, will discuss the company's efforts to grow the clinic footprint, accept a wider selection of insurance options, and its strategic outlook for the remainder of the yearVANCOUVER, BC, Sept. 8, 2022 - Delic Holdings Corp ("Delic") (CSE: DELC) ( OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and t... Read More...

Delic Announces Postponement of Meet Delic Conference

Meet Delic will now be held on October 14 and 15, 2023 in Las Vegas Tickets purchased for Meet Delic 2022 will be honored at next year's event VANCOUVER, BC, Sept. 6, 2022 - Delic Holdings Corp ("Delic") (CSE: DELC) ( OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today announced the postponement of... Read More...

Delic Announces Two Key Executive Appointments

Matt Stang, Co-founder and CEO of Delic, and Kevin Nicholson, COO of Delic, have been elevated to Executive Chairman and Chief Executive Officer, respectively. VANCOUVER, BC, Aug. 16, 2022 - Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today shared detail... Read More...

Delic Completes Offering Of Debentures

VANCOUVER, BC, July 29, 2022 - Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, is pleased to announce that it completed the sale of 1,240 units (the "Units") at a price of $1,000 per Unit for aggregate gross proceeds of $1,240,000, on July 27, 2022 (the "Clo... Read More...

Delic 2021 Revenue Shows Strong Growth as Nation’s Largest Ketamine Clinic Chain, Continues Expansion of Mental Health Wellness Services

Ketamine Wellness Centers (KWC) Approaches 100,000 Treatments, Expands FDA-Approved SPRAVATO® to Minneapolis, Salt Lake City, Dallas with More Locations Soon KWC, Serving the Most Patients in the U.S., Adds NAD+ Therapy and Launches Ketamine Wellness Integrated Therapist Directory VANCOUVER, BC, July 21, 2022 - Delic Holdings Corp ("DELI... Read More...

Delic Labs President and CSO Dr. Markus Roggen Named to Cannabis Scientist Power List for Third Consecutive Year

Under Dr. Roggen's leadership, Delic Labs will transfer their expertise and experience from the cannabis sector to establish itself as the leader in psychedelic research and safety testing. The lab has received Health Canada 56 exemptions for chemistry analytics on psilocybin mushrooms; to perform research and tests on a host of compound... Read More...

Delic Corp to Present Vision for Long-Term Growth and Industry-Leading Clinic Developments at First Annual H.C. Wainwright Mental Health Conference

June 27, 2022Held at the Lotte New York Palace Hotel, the inaugural event will feature a full day of company presentations, networking opportunities and one-on-one investor meetings with a focus on neuropsychiatry, psychedelics and more. During this year's conference, Stang will deliver a presentation that highlights the company's strateg... Read More...

Delic Corp to Present on Company’s Expansion Strategy, Industry Outlook at H.C. Wainwright Conference

Matt Stang, Co-founder and CEO of Delic Corp, will share the Company's strategic targets for the remainder of the year at the H.C. Wainwright Annual Global Life Sciences Conference from May 23-26 VANCOUVER, BC, May 18, 2022 - Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for ... Read More...

Delic Holdings Corp Provides Default Status Update

VANCOUVER, BC, May 16, 2022 - Delic Holdings Corp ("DELIC" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease Trade Orders ("... Read More...

Ketamine Wellness Centers Announces Partnership With The Veterans Administration (VA) in Arizona

Nation's Largest Ketamine Therapy Provider to Cover Out-Of-Pocket Costs for Veterans Experiencing Treatment-resistant Depression, PTSD and Anxiety GILBERT, Ariz., May 12, 2022 - Ketamine Wellness Centers (KWC), the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (... Read More...

Delic Holdings Corp Announces Late Filing Of Annual Financial Statements, Md&a And Management Cease Trade Order

VANCOUVER, BC, May 3, 2022 - Delic Holdings Corp ("DELIC" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, announces that as a result of delays to its audit, the Company's annual financial statements and accompanying management's discussion and analysis for the fiscal ye... Read More...

Delic Labs Receives Health Canada 56 Exemption to Conduct Research on MDMA, LSD and Other Psychedelic Compounds

Federally-licensed research lab received additional 56 Research Exemption to acquire psilocybin mushrooms from Nectar Health Sciences Laboratory Division Inc. VANCOUVER, BC, April 13, 2022 - Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today announced tha... Read More...

Delic Corp to Share Details of New Revenue Lines, Improved Outlook at Three Spring 2022 Investor Conferences

Matt Stang, Co-founder and CEO of Delic Corp, will outline the Company's strategic outlook for the remainder of the year at the Scottsdale Capital Event on April 22-24, Planet MicroCap Showcase on May 4, H.C. Wainwright Annual Global Life Sciences Conference on May 23-26 VANCOUVER, BC, March 23, 2022 - Delic Holdings Corp ("Delic") (CSE: ... Read More...

Survey Finds Majority of Affected Americans Approve of Psychedelics as an Alternative Treatment to Address Anxiety, Depression and PTSD

VANCOUVER, BC, Jan. 18, 2022 - A new survey conducted by The Harris Poll on behalf of Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), a leader in new medicines and treatments for a modern world, reports that nearly two thirds of Americans who suffer from anxiety/depression/PTSD (65%) believe that psy... Read More...

Delic Corp CEO to Participate in HC Wainwright Bioconnect Virtual Conference January 2022 Investor Conference

Matt Stang, Co-founder and CEO of Delic Corp, Will Present the Company's Strategic Outlook During the Conference, Jan 10-13 VANCOUVER, BC, Jan. 10, 2022 - Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today announced details regarding Matt Stang, co-found... Read More...

Delic Corp Announces Participation Details For January 2022 Investor Conferences

Matt Stang, Co-founder and CEO of Delic Corp, Will Present the Company's Strategic Outlook at HC Wainwright Bioconnect Virtual Conference Jan 10-13 and CEM's 8th Annual AlphaNorth Capital Conference Jan 21-23 VANCOUVER, BC, Dec. 9, 2021 - Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), a leader in ne... Read More...

Ketamine Wellness Centers (KWC) Announces Plans to Expand Operations into Salt Lake City and Reno

KWC Expands to Include 12 Locations by Q1 2022, Further Establishing its Position as the Nation's Largest Chain of Wellness Clinics, Adds to Delic's Network of Locations VANCOUVER, BC, Dec. 2, 2021 - Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), a leader in new medicines and treatments for a moder... Read More...

Delic Launches Industry’s First Family Support & Education Program at Ketamine Wellness Centers (KWC) Nationwide For Patient Community

Nation's Largest Chain of Ketamine Wellness Clinics Introduces First-of-Its-Kind Virtual Programming to Help Patients' Loved Ones Prepare for Life After Ketamine Infusion Experience VANCOUVER, BC, Nov. 18, 2021 - Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), a leader in new medicines and treatment... Read More...

Inaugural Meet Delic Experience Sells Out, Becomes World’s Largest Psychedelic and Wellness Event

"We're incredibly humbled and unbelievably inspired by the number of people who came out to Meet Delic and joined the conversation on the power of psychedelics to heal and to remove the stigmas surrounding them," said Jackee Stang, co-founder of Delic. "The world and our minds have evolved, and so should our medicines. We're already look... Read More...

Delic Completes Acquisition of Ketamine Wellness Centers (KWC), Becomes Largest Psychedelic Wellness Chain in United States

National Presence Across 10 States Provides Millions with Access to New Medicines and Treatments for a Variety of Health Conditions Twelve Operational Today, 15 Additional Clinics to Open within 18 Months Kevin Nicholson, CEO of KWC, Promoted to Chief Operating Officer for Delic Corp VANCOUVER, BC, Nov. 9, 2021 - Delic Holdings Corp. ("D... Read More...

Delic Announces Partnership with GT Research

Co-Marketing Agreement to Offer Computational Genetic Analysis and Trait Optimization for Cannabis and Psychedelics VANCOUVER, BC, Oct. 26, 2021 - Delic Holding Corp Inc. ("DELIC" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), a leader in new medicines and treatments for a modern world, today announced that its... Read More...

Ketamine Wellness Centers Partners with Veterans Affairs (VA) Community Care Network to Provide Free Ketamine Treatments to Veterans

Nation's Largest Clinic Chain's Partnership with Illinois and Minnesota Chapters to Provide Ketamine Treatments for PTSD, Depression and Pain at No Out-of-Pocket Cost VANCOUVER, BC, Oct. 14, 2021 - Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source) the leading psychedelic wellness platf... Read More...

Delic Labs Applies for Dealer’s License to Commercialize Psychedelics Research, Health Exemption to Test MDMA and LSD

License Allows Authority to Work with Additional Banned Substances and Market the Research for Medical Purposes VANCOUVER, BC, Oct. 6, 2021 - Delic Holding Corp Inc. ("DELIC" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), the leading psychedelic wellness platform, today announced Delic Labs has applied for a He... Read More...

Delic Partnership with Paradigm Healthcare of Georgia Brings Clinically Relevant Toxicology Testing to Ketamine Treatment for First Time

Psychedelic Treatment Chain Ketamine Infusion Centers Will Leverage State-of-the-Art Toxicology Testing Solution to Ensure Highest Quality Results Across Locations VANCOUVER, BC, Sept. 30, 2021 - Delic Holding Corp Inc. ("DELIC" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (original source), the leading psychedelic wellness pl... Read More...

Delic Closes C$7.0 Million Private Placement With U.S. Institutional Investor to Fuel Growth of Largest National Presence

Funding to Open New Psychedelic Wellness Clinic Locations, Adding to Leading Footprint /NOT FOR DISSEMINATION IN THE UNITED STATES OR TO U.S. NEWSWIRE SERVICES/ VANCOUVER, BC, Sept. 29, 2021 - Delic Holdings Corp. ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) is pleased to announce that it has closed its previously anno... Read More...

Lamar Odom and His Life-Saving Journey with Psychedelics

In 2015 Odom was hospitalized in Las Vegas after a near-death overdose that resulted in multiple seizures, strokes and a coma. The upcoming documentary Lamar Odom Reborn chronicles his life, from past traumas and struggles with anxiety and substance abuse to his recovery and healing through psychedelic treatments, meditation and breathwo... Read More...

Delic Announces C$7.0 Million Private Placement With Institutional Investor

/NOT FOR DISSEMINATION IN THE UNITED STATES OR TO U.S. NEWSWIRE SERVICES/ VANCOUVER, BC, Sept. 23, 2021 - Delic Holdings Corp. ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) is pleased to announce that it has entered into a securities purchase agreement with a single institutional investor for gross proceeds of approxima... Read More...